Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Mo | Reviva Pharmaceuticals: Reviva Reports Full Year 2024 Financial Results and Recent Business Highlights | ||
Mo | Fortress Biotech, Inc.: Fortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights | ||
Mo | Rekor Systems Reports Strong 2024 Financial Results Highlighted by Record Revenue and Significant Operational Improvements | ||
Mo | Allarity Therapeutics, Inc.: Allarity Therapeutics Reports Full Year 2024 Financial Results and Provides a Business Update | ||
Mo | Rani Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Corporate Update | ||
Mo | Aqua Metals Reports Milestone Advancements, Strategic Progress, and Sierra ARC Lithium Battery Recycling Campus Developments in 2024 | ||
Mo | Open Lending Corporation: Open Lending Reports Fourth Quarter and Full Year 2024 Financial Results | ||
Mo | INNOVATE Corp. Announces Fourth Quarter and Full Year 2024 Results | ||
Mo | Open Lending Corporation: Open Lending Announces Leadership Changes | ||
Mo | Ardelyx, Inc.: Ardelyx to Share a Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH (tenapanor) at the National Kidney Foundation Spring Clinical Meetings | ||
Mo | Helport AI, Inc.: Helport AI Reports First Half Fiscal Year 2025 Financial Results | ||
Mo | Daré Bioscience, Inc.: Daré Bioscience Reports Full Year 2024 Financial Results and Provides Company Update | ||
Mo | Bionano Genomics: Bionano Reports Fourth Quarter and Full-Year 2024 Results and Provides Revenue Outlook for 2025 | ||
Mo | Ascendis Pharma: Ascendis Submits U.S. NDA for TransCon CNP (Navepegritide) for the Treatment of Children with Achondroplasia | ||
Mo | Celcuity Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update | ||
Mo | Gray Media: Gray Announces AR Securitization Facility increase to $400 million and extension to 2028 and Revolving Credit Facility increase to $700 million | ||
Mo | Kirby Corporation Announces Date for 2025 First Quarter Earnings Release and Earnings Webcast | ||
Mo | Positron Corp.: Positron Corporation Secures $8 Million in Capital to Accelerate Growth and Market Expansion | ||
Mo | GDEV Inc.: GDEV announces results for the fourth quarter and full year 2024 | ||
Mo | Yoshiharu Global Co.: Yoshiharu Regains Compliance with NASDAQ Stockholders' Equity Requirement | ||
Mo | Eagle Pharmaceuticals, Inc.: Eagle Pharmaceuticals Announces $69 Million Agreement to Monetize BENDEKA Royalties | ||
Mo | Red Cat Holdings, Inc.: Red Cat Holdings Reports Financial Results for the 2024 Transition Period (as of December 31, 2024 and the eight months then ended) and Provides Corporate Update | ||
Mo | Dogwood Therapeutics, Inc.: Dogwood Therapeutics Announces Fourth Quarter and Full Year 2024 Financial Results | ||
Mo | Groupe Casino: Information regarding buy-out of minority shareholders of Cnova N.V. | ||
Mo | Nokia Oyj: Repurchase of own shares on 31.03.2025 |